VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,068 | +3.6% | 2,339 | +21.3% | 0.00% | 0.0% |
| Q2 2023 | $30,944 | +81331.6% | 1,928 | -60.1% | 0.00% | 0.0% |
| Q1 2023 | $38 | +280.0% | 4,834 | +810.4% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 531 | -65.4% | 0.00% | -100.0% |
| Q3 2022 | $33,000 | +73.7% | 1,535 | +7.3% | 0.00% | – |
| Q2 2022 | $19,000 | +280.0% | 1,430 | +530.0% | 0.00% | – |
| Q1 2022 | $5,000 | -64.3% | 227 | -57.8% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 538 | -11.1% | 0.00% | – |
| Q3 2021 | $10,000 | – | 605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |